Publications Database

Brett , Cohen I. (2002)

Use of a GABA-transaminase agonist for treatment of infantile autism.

Medical Hypotheses

59(1), pp. 115-116

Read Abstract (New Window)

Brown D. (1996)

Autism, asperger's syndrome and the crick-mitchison theory of the biological function of REM sleep.

Medical Hypotheses

47(5), pp. 399-403

Read Abstract (New Window)

Brown N. , Panksepp J. (2008)

Low-dose naltrexone for disease prevention and quality of life.

Medical Hypotheses

72(3), pp. 333-337

Read Abstract (New Window)

Brudnak M. A. (2001)

Application of genomeceuticals to the molecular and immunological aspects of autism.

Medical Hypotheses

57(2), pp. 186-191

Read Abstract (New Window)

Brudnak M. A. et al. (2002)

Enzyme-based therapy for autism spectrum disorders: is it worth another look?

Medical Hypotheses

58(5), pp. 422-428

Read Abstract (New Window)

Brudnak M. A. (2002)

Probiotics as an adjuvant to detoxification protocols.

Medical Hypotheses

58(5), pp. 382-385

Read Abstract (New Window)

Cannell J. J. (2008)

Autism and vitamin D.

Medical Hypotheses

70(4), pp. 750-759

Read Abstract (New Window)

Chen F. et al. (2006)

Sleep problems and information processing, a "disconnection effect" in autism?

Medical Hypotheses

66(6), pp. 1245-1246

Emanuele E. et al. (2007)

Pioglitazone as a therapeutic agent in autistic spectrum disorder.

Medical Hypotheses

69(3), pp. 699

Finegold S. M. (2007)

Therapy and epidemiology of autism-clostridial spores as key elements.

Medical Hypotheses

Read Abstract (New Window)

Geier M. R. , Geier D. A. (2005)

The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity.

Medical Hypotheses

64(3), pp. 46-54.

Read Abstract (New Window)

Gesundheit B. et al. (2015)

Therapeutic properties of mesenchymal stem cells for autism spectrum disorders.

Medical Hypotheses

March, 84(3), pp. 169-177.

Read Abstract (New Window)

Good P. (2006)

Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?

Medical Hypotheses

67(3), pp. 671-672

Hendren. R. L. et al. (2009)

Mechanistic biomarkers for autism treatment.

Medical Hypotheses

73(6), pp. 950-954.

Read Abstract (New Window)

Kuhn M. et al. (2012)

Long term antibiotic therapy may be an effective treatment for children co-morbid with Lyme disease and autism spectrum disorder.

Medical Hypotheses

78(5), pp. 606-615.

Read Abstract (New Window)

Ramachandran V. , Seckel E. (2011)

Synchronized dance therapy to stimulate mirror neurons in autism.

Medical Hypotheses

76(1), pp. 150-151

Read Abstract (New Window)

Rossignol D. A. (2007)

Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism.

Medical Hypotheses

68(6), pp. 1208-1227

Read Abstract (New Window)

Tsai S. (2005)

Could repetitive transcranial magnetic stimulation be effective in autism?

Medical Hypotheses

64(5), pp. 1070-1071

Wachtel L. E. , Dhossche D. M. , Kellner C. H. (2011)

When is electroconvulsive therapy appropriate for children and adolescents?

Medical Hypotheses

76(3), pp. 395-399.

Read Abstract (New Window)

Zhu H. et al. (2001)

Mirror neural training induced by virtual reality in brain-computer interfaces may provide a promising approach for the autism therapy.

Medical Hypotheses

76(5), pp. 646-647.

Read Abstract (New Window)